MedTrace Logo

Absorption of Corticosteroids in Children With Juvenile Dermatomyositis

NCT00004357 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2011-07-22

No results posted yet for this study

Summary

Juvenile dermatomyositis (JDM) is a connective tissue disease that causes skin rash and weak muscles in children. The purpose of this study is to measure the absorption of oral prednisolone and intravenous (IV) methylprednisolone and to determine levels of disease activity indicators in the blood. These levels will be compared to see if there are patterns specific to active and less active JDM.

Conditions

  • Vasculitis, Hypersensitivity
  • Connective Tissue Diseases
  • Dermatomyositis
  • Vasculitis

Interventions

DRUG

Methylprednisolone

IV

DRUG

Prednisolone

Oral

Sponsors & Collaborators

Principal Investigators

  • Lauren M. Pachman, MD · Northwestern University Feinberg School of Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-09-30
Primary Completion
2005-12-31
Completion
2008-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004357 on ClinicalTrials.gov